The family of a Melbourne woman who was brutally killed by her partner say they're distraught after the man was found not ...
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia ...
Congress’ Medicare advisory committee has made it clear that much work still needs to be done to bring alignment to post-acute care regulatory and payment matters. Medicare Payment Advisory Commission ...
Electronic health record providers are starting work that could transform how nursing homes grapple with prior authorization requests and length of stay determinations.
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...
Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...
We expect relief after a mental health crisis but many feel shame instead. This “Recovery Paradox” can quietly stall healing ...
Black race is an independent prognostic factor for shorter survival in acute myeloid leukemia independent of cytogenetic profiles, according to study results presented at ASH Annual Meeting and ...
Among fit patients with acute myeloid leukemia, the combination of azacitidine plus Venclexta (venetoclax) was associated ...
The goal of the nation’s first all-electric acute care hospital opening next week in California is to treat patients without ...
A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a ...
Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results